MCID: CHL039
MIFTS: 31

Choledocholithiasis malady

Category: Gastrointestinal diseases

Aliases & Classifications for Choledocholithiasis

About this section

Aliases & Descriptions for Choledocholithiasis:

Name: Choledocholithiasis 10 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:11755
MeSH36 D042883
UMLS65 C0701818

Summaries for Choledocholithiasis

About this section
Wikipedia:68 A gallstone, also called a cholelith, is a stone formed within the gallbladder out of bile components.... more...

MalaCards based summary: Choledocholithiasis is related to pseudomyxoma peritonei and paracoccidioidomycosis. An important gene associated with Choledocholithiasis is GPT (Glutamic-Pyruvate Transaminase (Alanine Aminotransferase)), and among its related pathways are Folate biosynthesis and FOXA2 and FOXA3 transcription factor networks. Affiliated tissues include brain, t cells and liver.

Related Diseases for Choledocholithiasis

About this section

Diseases related to Choledocholithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 525)
idRelated DiseaseScoreTop Affiliating Genes
1pseudomyxoma peritonei30.1ALPL, ALPP
2paracoccidioidomycosis30.1ALPL, ALPP
3uremia30.1ALPL, ALPP
4villonodular synovitis29.9ALPL, ALPP
5neonatal jaundice29.9ALB, UGT1A1
6splenic abscess29.8ALB, F2
7suppurative cholangitis29.8ABCB4, ALB, ALPP
8hepatitis b29.4ALB, F2, GPT, SLC17A5
9alopecia29.4ALB, F2
10pneumoconiosis29.3ALB, F2
11liver disease29.1ALB, ALPP, F2, GPT, SLC17A5
12t cell deficiency29.1ALB, ALPL, ALPP, F2
13hepatocellular carcinoma28.9ABCB4, ALB, ALPP, F2, GPT
14methanol poisoning10.4GPT, SLC17A5
15pyruvate kinase deficiency, liver type10.4GPT, SLC17A5
16secondary sclerosing cholangitis10.4
17nondystrophic myotonia10.4GPT, SLC17A5
18hemorrhagic proctocolitis10.3GPT, SLC17A5
19temporal arteritis10.3ALPP, SLC17A5
20anaerobic meningitis10.3ALPL, ALPP
21breast adenocarcinoma10.3ALPL, ALPP
22cervical adenitis10.3ALPL, ALPP
23internal auditory canal meningioma10.3ALPL, ALPP
24malignant histiocytosis10.3ALPL, ALPP
25achondrogenesis10.3ALPL, ALPP
26postgastrectomy syndrome10.3ALPL, ALPP
27arteritic anterior ischemic optic neuropathy10.3ALPL, ALPP
28fibrogenesis imperfecta ossium10.3ALPL, ALPP
29mixed cell type adenoma of parathyroid10.3ALPL, ALPP
30xanthogranulomatous cholecystitis10.3ALPL, ALPP
31axial osteomalacia10.3ALPL, ALPP
32brawny scleritis10.3ALPL, ALPP
33ovary rhabdomyosarcoma10.3ALPL, ALPP
34social phobia10.3ALPP, SLC17A5
35pancreatic ductal carcinoma10.3ALPL, ALPP
36larynx carcinoma in situ10.3ALPL, ALPP
37hypophosphatasia, infantile10.3ALPL, ALPP
38gingival disease10.3ALPL, ALPP
39macrocytic anemia10.3ALPL, ALPP
40cholestasis10.3ALB, GPT
41testicular germ cell cancer10.3ALPL, ALPP
42bartholin's gland adenocarcinoma10.3ALPL, ALPP
43geotrichosis10.3ALPL, ALPP
44dendritic cell thymoma10.3ALPL, ALPP
45central nervous system germ cell tumor10.3ALPL, ALPP
46venezuelan hemorrhagic fever10.3ALPL, ALPP
47hemometra10.3ALPL, ALPP
48diamond-blackfan anemia 410.3ALPL, ALPP
49alzheimer disease-210.3ALPL, ALPP
50central nervous system sarcoma10.3ALPL, ALPP

Graphical network of the top 20 diseases related to Choledocholithiasis:



Diseases related to choledocholithiasis

Symptoms for Choledocholithiasis

About this section

Drugs & Therapeutics for Choledocholithiasis

About this section

Drugs for Choledocholithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
EtomidateapprovedPhase 45733125-97-236339, 667484
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Etomidate
(+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-etomidate
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
(d)-Etomidate
1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester
1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester
15301-65-2
1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
33125-97-2
AC-5898
AC1L1VLF
AC1Q34BV
AC1Q64LP
AKOS000548952
Absele
Amidate
Amidate (TN)
Amidate (pharmaceutical)
Amidate, Etomidate
BAS 01947657
BRN 0665833
C07522
C14H16N2O2
CHEBI:129025
CHEMBL23731
CID36339
CPD000010931
D-Etomidate
D005045
D00548
 
DB00292
EINECS 251-385-9
Ethnor
Ethomidate
Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
Etomidate
Etomidate (USAN/INN)
Etomidate [USAN:BAN:INN]
Etomidato
Etomidato [INN-Spanish]
Etomidatum
Etomidatum [INN-Latin]
Etomidic acid
HMS1571A04
HMS1612G10
HMS2093P17
Hypnomidate
LS-78232
MLS000034952
MLS001240191
MolPort-000-917-569
Prestwick0_001041
Prestwick1_001041
Prestwick2_001041
R 16659
R 26490
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-26490
R26490
Radenarcon
Radenarkon
S1329_Selleck
SAM002548930
SBB066197
SMR000010931
SPBio_002901
UNII-Z22628B598
ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
2
MeperidineapprovedPhase 46557-42-14058
Synonyms:
1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]
1-Methyl-4-phenylisonipecotic acid, ethyl ester
1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester
4-Carbethoxy-1-methyl-4-phenylpiperidine
4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester
50-13-5 (hydrochloride)
57-42-1
610593_ALDRICH
610593_FLUKA
AC1L1HBJ
C07128
CHEBI:122528
CHEMBL607
CID4058
D008614
D08343
DB00454
DEA No. 9230
Demarol
Demerol
DivK1c_000983
Dolcontral
Dolosal
Dolsin
EINECS 200-329-1
Ethyl 1-methyl-4-phenylisonipecotate
Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate
HSDB 3116
IDI1_000983
Isonipecain
Isonipecaine
Isonipecaïne
Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester
KBio1_000983
L000908
LS-85121
 
Lidol
Lydol
Meperidine
Meperidine Hydrochloride
Meperidine hydrochloride
Meperidine solution
Meperidol
Methyl phenylpiperidine carbonic acid ethyl ester
MolPort-001-785-564
N-Methyl-4-phenyl-4-carbethoxypiperidine
NINDS_000983
Nemerol
Operidine EPJ I
Operidine EPJ-I
Pethanol
Pethidin
Pethidine
Pethidine (INN)
Pethidine DBL
Pethidine DBL (TN)
Pethidine dbl
Pethidine hydrochloride
Pethidineter
Pethidinum
Pethidinum [INN-Latin]
Petidina
Petidina [INN-Spanish]
Petydyna
Petydyna [Polish]
Phetidine
Piperosal
Pipersal
Péthidine
Sauteralgyl
Spasmedal
Spasmodolin
UNII-9E338QE28F
YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)
meperidine
3
Midazolamapproved, illicitPhase 463559467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
Dormicum
 
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam Hydrochloride
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
4
Ursodeoxycholic acidapproved, investigationalPhase 478128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
ISO-URSODEOXYCHOLIC ACID
 
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol Tablets, 250 mg
Ursodiol Tablets, 500 mg
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
5Neurotransmitter AgentsPhase 414795
6NarcoticsPhase 42709
7Psychotropic DrugsPhase 45501
8Gastrointestinal AgentsPhase 46401
9Tranquilizing AgentsPhase 43597
10AnalgesicsPhase 49358
11Peripheral Nervous System AgentsPhase 418510
12AnestheticsPhase 47385
13Analgesics, OpioidPhase 42304
14Hypnotics and SedativesPhase 42032
15Anesthetics, GeneralPhase 42274
16Anesthetics, IntravenousPhase 41943
17GABA ModulatorsPhase 4657
18Central Nervous System DepressantsPhase 410016
19Anti-Anxiety AgentsPhase 41529
20Antibiotics, Antitubercular5971
21Anti-Bacterial Agents9140
22glucagon379
23Glucagon-Like Peptide 1620
24Scopolamine hydrobromide58114-49-8
25Butylscopolammonium Bromide58
26Tissue Plasminogen ActivatorPhase 0202
27Plasminogen InactivatorsPhase 010
28PlasminogenPhase 0198
29Plasminogen Activator Inhibitor 1Phase 027

Interventional clinical trials:

(show all 36)
idNameStatusNCT IDPhase
1Etomidate vs. Midazolam for Sedation During ERCPCompletedNCT02027311Phase 4
2UDCA for Symptomatic Gallstone DiseaseCompletedNCT00161083Phase 4
3Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the PapillaRecruitingNCT02703077Phase 4
4Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD StonesCompletedNCT02592811Phase 3
5Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary ObstructionTerminatedNCT01424657Phase 3
6Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBDCompletedNCT01673269
7Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely CholedocholithiasisCompletedNCT00807729
8Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP CholangitisCompletedNCT02594891
9Left Lateral Position and Prone Position for Endoscopic Retrograde CholangiopancreatographyCompletedNCT02594475
10Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic CholecystectomyCompletedNCT02037958
11Loop-tipped Guidewire in Selective Biliary CannulationCompletedNCT02028845
12Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic CholecystectomyCompletedNCT01824186
13Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall StonesCompletedNCT01683240
14Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted StoneCompletedNCT00173368
15Comparison Between Pre and Intraoperative ERCP in Treatment of Common Bile Duct StonesCompletedNCT01046552
16Early EUS in Acute Biliary PancreatitisCompletedNCT02430285
17Routine Bile Collection for Microbiological Analysis During CholangiographyCompletedNCT01003782
18Cytological Evaluation of Biliary Epithelium After Endoscopic SphincterotomyCompletedNCT01135732
19Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic PancreatitisCompletedNCT02781987
20Comparison of LCBDE vs ERCP + LC for CholedocholithiasisRecruitingNCT02515474
21Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/CholedocholithiasisRecruitingNCT00416234
22Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCPRecruitingNCT02611453
23Laser Versus Mechanical Lithotripsy of Bile Duct StonesRecruitingNCT01759979
24A Prospective Randomized Study Comparing Different Dilation Durations for Endoscopic Papillary Balloon DilatationRecruitingNCT00451581
25Optimization and Cost-effective Analysis of Secondary Biliary Stones' ManagementsRecruitingNCT02554097
26Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersRecruitingNCT01438385
27Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde CholangiopancreatogrRecruitingNCT01414400
28Los Angeles Prospective GI Biliary and EUS SeriesRecruitingNCT02196935
29Prospective Validation of "Cholecystectomy First" Strategy for Gallstone MigrationActive, not recruitingNCT02461147
30Comparison of Papillary Balloon Dilatation Vs.Sphincterotomy for Lithotripsy in Difficult Sphincterotomy or Distal CBD TaperingActive, not recruitingNCT00329888
31Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary PancreatitisActive, not recruitingNCT01687959Phase 0
32The Clinical Characteristics of the Patients With Choledocholithiasis Without CholangitisEnrolling by invitationNCT02647593
33Direct Peroral Cholangioscopy by Using an Ultra-slim Upper EndoscopeEnrolling by invitationNCT02276157
34Study Investigating the Best Method of Treatment of Bile Duct Stones in Higher Risk PatientsTerminatedNCT00612846
35Management of Common Bile Duct (CBD) Stones at Laparoscopic CholecystectomyTerminatedNCT00124033
36Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone ClearanceWithdrawnNCT01475864

Search NIH Clinical Center for Choledocholithiasis


Cochrane evidence based reviews: choledocholithiasis

Genetic Tests for Choledocholithiasis

About this section

Anatomical Context for Choledocholithiasis

About this section

MalaCards organs/tissues related to Choledocholithiasis:

33
Brain, T cells, Liver, Endothelial, Breast, Lung, Eye

Animal Models for Choledocholithiasis or affiliated genes

About this section

Publications for Choledocholithiasis

About this section

Articles related to Choledocholithiasis:

(show top 50)    (show all 555)
idTitleAuthorsYear
1
Non-enhancing subcortical white matter lesions in central nervous system Listeriosis. (25650539)
2015
2
Glatiramer acetate and nanny proteins restrict access of the multiple sclerosis autoantigen myelin basic protein to the 26S proteasome. (25276831)
2014
3
N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor. (23724116)
2013
4
Hypokalemic myopathy in inflammatory bowel diseases. (23339931)
2013
5
The effect of the Chinese Cultural Revolution and Great Leap Forward on the prevalence of myopia. (24197389)
2013
6
What Would Be the Most Appropriate I+/I^ Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer. (24350266)
2013
7
Alexithymia is associated with an augmenter profile, but not only: evidence for anticipation to arousing music. (22962856)
2012
8
Pegylated interferon-I+2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus. (22154462)
2012
9
FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer. (22526901)
2012
10
Holter monitoring and long-term prognosis in hypertrophic cardiomyopathy. (22722267)
2012
11
A critical re-evaluation of CD24-positivity of human embryonic stem cells differentiated into pancreatic progenitors. (22529013)
2012
12
Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. (23052311)
2012
13
Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication. (21704786)
2011
14
Outcome analysis and outcome predictors of traumatic head injury in childhood: Analysis of 454 observations. (21769206)
2011
15
Parental wisdom, empirical blindness, and normative evaluation of prenatal genetic enhancement. (21597084)
2011
16
Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses. (21235430)
2011
17
Pentoxifylline attenuates TNF-I+ protein levels and brain edema following temporary focal cerebral ischemia in rats. (21219888)
2011
18
Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1. (21248772)
2011
19
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. (21602453)
2011
20
Ankylosis of permanent first molars: genetics or environment? A case report of a discordant twin pair. (21288789)
2011
21
Ghrelin and peptide YY in postpartum lactating and nonlactating women. (20007306)
2010
22
Acetylcholinesterase: from 3D structure to function. (20138030)
2010
23
Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). (19477063)
2009
24
Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis. (18804099)
2008
25
Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth. (18430085)
2008
26
Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials. (17234987)
2007
27
Expression of an active LKB1 complex in cardiac myocytes results in decreased protein synthesis associated with phenylephrine-induced hypertrophy. (17098823)
2007
28
Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin. (17239458)
2007
29
The natural product berberine is a human prolyl oligopeptidase inhibitor. (17295371)
2007
30
Erythrocyte oxidative damage in chronic fatigue syndrome. (17174731)
2007
31
Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. (16532456)
2006
32
Knowledge and opinions of orthopaedic surgeons concerning medical evaluation and treatment of patients with osteoporotic fracture. (16391245)
2006
33
Malignant glioma: the involvement of loss of allelic heterozygosity and PTEN mutations in a group of Malay patients. (16124450)
2005
34
SGK1-mediated fibronectin formation in diabetic nephropathy. (16301823)
2005
35
Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1. (15028714)
2004
36
P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. (14599865)
2003
37
The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland. (14630397)
2003
38
Structure and expression of the follicle-stimulating hormone receptor gene in a marsupial, Macropus eugenii. (12211057)
2002
39
Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC. (11438451)
2001
40
Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. (10926955)
2000
41
Feigrisolides A, B, C and D, new lactones with antibacterial activities from Streptomyces griseus. (11099227)
2000
42
The relationship between vascular endothelial growth factor, microvascular density, lymph node metastasis and prognosis of breast carcinoma]. (11866906)
2000
43
Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. (9279252)
1997
44
Dissecting desaturation: plants prove advantageous. (15157478)
1996
45
The neuroendocrine chaperone 7B2 can enhance in vitro POMC cleavage by prohormone convertase PC2. (7672117)
1995
46
Epidermal cell proliferation and terminal differentiation in skin organ culture after topical exposure to sodium dodecyl sulphate. (8564064)
1995
47
Hemangioblastomas of the central nervous system--immunohistochemical and ultrastructural study. (1700315)
1990
48
Lymphocyte subpopulation in essential mixed cryoglobulinemia. (3486282)
1986
49
Hepatic disease in the Spanish toxic oil syndrome. A thirty months follow-up study. (3745885)
1986
50
A sympathetic ganglioneuroma cultivated in vitro. (18875037)
1948

Variations for Choledocholithiasis

About this section

Expression for genes affiliated with Choledocholithiasis

About this section
Search GEO for disease gene expression data for Choledocholithiasis.

Pathways for genes affiliated with Choledocholithiasis

About this section

Pathways related to Choledocholithiasis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6ALPL, ALPP
29.3ALB, F2
3
Show member pathways
7.1ABCB4, ALB, ALPL, ALPP, GPT, GUSB

GO Terms for genes affiliated with Choledocholithiasis

About this section

Biological processes related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to organic substanceGO:00100339.5ALB, UGT1A1

Sources for Choledocholithiasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet